MAP
AMGN icon

Moody Aldrich Partners’s Amgen AMGN Stock Holding History

Moody Aldrich Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,202
Closed -$910K – 198
2024
Q1 		$910K Sell
3,202
-1
-0% -$293 0.15% 121
2023
Q4 		$923K Buy
3,203
+4
+0.1% +$1.09K 0.17% 119
2023
Q3 		$860K Buy
+3,199
New +$798K 0.16% 119

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Moody Aldrich Partners's AMGN Position: Q2 2024 in Review

Moody Aldrich Partners sold out of Amgen (AMGN) in Q2 2024, closing a stake of 3,202 shares — an estimated $910K sold.

Moody Aldrich Partners first reported a position in AMGN in Q3 2023 and held it in 3 quarters. The position peaked at $923K in Q4 2023. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Moody Aldrich Partners reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Moody Aldrich Partners sold 3,202 Amgen shares in Q2 2024, an estimated $910K.
  • Moody Aldrich Partners first reported a position in Amgen in Q3 2023 and held it in 3 quarters.
  • Moody Aldrich Partners's Amgen position peaked at $923K in Q4 2023.
  • 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Moody Aldrich Partners's 13F filing for Q2 2024, filed 24 Jul 2024.